TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.4, ss.1781-1790, 2021 (SCI-Expanded)
Background/aim: This study aimed to evaluate the efficacy of rituximab in children with difficult-to-treat nephrotic syndrome, considering the type of disease (steroid-sensitive or -resistant) and the dosing regimen.